Every trade that managers of Fleury SA disclose to CVM (Brazil) is tracked on this page. The company sits in the Food & Beverage sector and is based in São Paulo, Brazil. It was founded in 1926. Between 23 October 2025 and 23 October 2026, 2 insiders published 57 filings.
Purchases and sales both appear in the filings: 2 purchases (1 insider, €20k) and 10 sales (2 insiders, €788k). Netting one side against the other leaves €768k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €195k, the sale published on 10 October 2026 is the largest of the period (0.0075% of market cap). Those buying include 1 board member.
With 57 filings in twelve months, the company is more active than the median of 23 filings across the 343 companies we follow on the same exchange. Since 2018, the database holds 105 purchases and 128 sales by insiders of the company.
The last insider purchase was made public on 23 August 2026, 62 days ago. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
These figures are compiled from regulatory filings published by CVM (Brazil). They describe what insiders did and are not a recommendation.
Headquarters: São Paulo, Brazil · Founded: 1926
Source: Wikidata (CC0).
Analysts rate Fleury SA Hold (neutral), based on 12 analysts. Average price target: R$22.17.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 554 declarations
Fleury SA is a Brazilian company specializing in healthcare services, particularly in laboratory medicine and diagnostics. It is listed on the São Paulo Stock Exchange, BVMF.